His primary areas of study are Gene silencing, RNA interference, Small interfering RNA, Pharmacology and In vivo. Antonin de Fougerolles has included themes like Molecular biology and Computational biology in his RNA interference study. His Small interfering RNA study is concerned with the larger field of RNA.
The various areas that Antonin de Fougerolles examines in his RNA study include Nucleic acid and Rational design. His In vivo research includes elements of Receptor, Biochemistry, Gene, Endogeny and Apolipoprotein E. Many of his research projects under Biochemistry are closely connected to Primary and Asialoglycoprotein receptor with Primary and Asialoglycoprotein receptor, tying the diverse disciplines of science together.
Antonin de Fougerolles focuses on Biochemistry, Polynucleotide, Molecular biology, Nucleic acid and Cell biology. In his research, Cell, Nucleic acid molecule and A protein is intimately related to Function, which falls under the overarching field of Biochemistry. His work is dedicated to discovering how Polynucleotide, Stereochemistry are connected with Untranslated region and other disciplines.
His Molecular biology research is multidisciplinary, incorporating elements of RNA, RNA interference, Gene, Immunoglobulin superfamily and Intercellular adhesion molecule. The study incorporates disciplines such as Gene silencing and Virology in addition to RNA. His Gene silencing study incorporates themes from Cancer research, Computational biology, In vivo and RNAi Therapeutics.
Antonin de Fougerolles mostly deals with Polynucleotide, Biochemistry, Nucleic acid, Stereochemistry and Molecular biology. His work deals with themes such as Messenger RNA, Immunology and Cell biology, which intersect with Polynucleotide. His work on Protein biosynthesis as part of general Biochemistry study is frequently linked to Molecule, bridging the gap between disciplines.
His study on Nucleic acid also encompasses disciplines like
His scientific interests lie mostly in Polynucleotide, Biochemistry, Primary, Nucleic acid and Molecular biology. His Polynucleotide study combines topics from a wide range of disciplines, such as RNA, Immunology and Cell biology. His work carried out in the field of RNA brings together such families of science as Polymerase, Enzyme and Stereochemistry.
His Biochemistry research incorporates themes from UDP glucuronosyltransferase 1 family, polypeptide A1 and Function. He interconnects Protein subcellular localization prediction and Nucleoside in the investigation of issues within Nucleic acid. His studies in Molecular biology integrate themes in fields like Cellular receptor and Virology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7.
Veit Hornung;Margit Guenthner-Biller;Carole Bourquin;Andrea Ablasser.
Nature Medicine (2005)
Interfering with disease: a progress report on siRNA-based therapeutics.
Antonin de Fougerolles;Hans Peter Vornlocher;John Maraganore;Judy Lieberman.
Nature Reviews Drug Discovery (2007)
Rational design of cationic lipids for siRNA delivery
Sean C Semple;Akin Akinc;Jianxin Chen;Ammen P Sandhu.
Nature Biotechnology (2010)
A combinatorial library of lipid-like materials for delivery of RNAi therapeutics
Akin Akinc;Andreas Zumbuehl;Andreas Zumbuehl;Michael Goldberg;Elizaveta S Leshchiner.
Nature Biotechnology (2008)
Lipid-like materials for low-dose, in vivo gene silencing
Kevin T. Love;Kerry P. Mahon;Christopher G. Levins;Kathryn A. Whitehead.
Proceedings of the National Academy of Sciences of the United States of America (2010)
Therapeutic RNAi targeting PCSK9 acutely lowers plasma cholesterol in rodents and LDL cholesterol in nonhuman primates
Maria Frank-Kamenetsky;Aldo Grefhorst;Norma N. Anderson;Timothy S. Racie.
Proceedings of the National Academy of Sciences of the United States of America (2008)
Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms.
Akin Akinc;William Querbes;Soma De;June Qin.
Molecular Therapy (2010)
The α1β1 and α2β1 Integrins Provide Critical Support for Vascular Endothelial Growth Factor Signaling, Endothelial Cell Migration, and Tumor Angiogenesis
Donald R. Senger;Carole A. Perruzzi;Michael Streit;Victor E. Koteliansky.
American Journal of Pathology (2002)
Hyperoxia causes angiopoietin 2-mediated acute lung injury and necrotic cell death.
Vineet Bhandari;Rayman Choo-Wing;Chun G Lee;Zhou Zhu.
Nature Medicine (2006)
Delivery vehicles for small interfering RNA in vivo.
Antonin R. de Fougerolles.
Human Gene Therapy (2008)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Alnylam Pharmaceuticals (United States)
Alnylam Pharmaceuticals (United States)
Biogen (United States)
Alnylam Pharmaceuticals (United States)
MIT
Boston Children's Hospital
United States Department of the Army
University Hospital Bonn
Ludwig-Maximilians-Universität München
Louisiana State University Health Sciences Center Shreveport
University of California, San Diego
NortonLifeLock (United States)
Imperial College London
National Research Council Canada
University of Southern California
Spanish National Research Council
Osaka University
Ruhr University Bochum
National Oceanic and Atmospheric Administration
University of New South Wales
The University of Texas at Austin
Tehran University of Medical Sciences
The University of Texas Medical Branch at Galveston
Erasmus University Rotterdam
University of Southern California
Smithsonian Institution